Healthcare Costs & Access

Health-care pricing, access, provider rules, and delivery-system reform not specific to a program.

102 events unlock with a free account

36 grant announcements65 rulemakings this week1 press release

Create free account →

July 2026

Rulemaking

Notice · Environmental Protection Agency · Jul 22EPA

AR-226-0022 - Addendum Epidemiology Protocol: An Epidemiologic Analysis of the Inpatient and Outpatient Claims Event and Episode Experience of 3M Decatur Employees, 1993-1998

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: James Badman, Mesa, AZ; Permit No. PER33159692

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Nicholas Austin Hardin, Houston, TX; Permit No. PER33006943

Notice · U.S. Fish and Wildlife Service · Jul 22FWS

Applicant: Mathew Olsen, Victoria, TX; Permit No. PER33005203

Notice · Food and Drug Administration · Jul 22FDA

Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Rasuvo (Methotrexate) Solution, 27.5 Milligrams/0.55 Milliliter (27.5 Milligrams/0.55 Milliliter)

Notice · Food and Drug Administration · Jul 22FDA

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Premarket Notifications Submission

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021527 - Draft Guidance on Ipratropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_203214 - Draft Guidance on Tofacitinib Citrate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_205739 - Draft Guidance on Patiromer Sorbitex Calcium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021395 - Draft Guidance on Tiotropium Bromide

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_210115 - Draft Guidance on Tacrolimus

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_009218-Sol - Draft Guidance on Warfarin Sodium

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_021433 - Draft Guidance on Fluticasone Propionate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_212801 - Draft Guidance on Osilodrostat Phosphate

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_019561 - Draft Guidance on Potassium Chloride

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_022008 - Draft Guidance on Ropinirole Hydrochloride

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_050708 - Draft Guidance on Tacrolimus

Comment period closed · Food and Drug Administration · Jul 22FDAClosed

PSG_008816 - Draft Guidance on Lidocaine Hydrochloride

Upcoming deadlines

CMS-10434 #47 (Health Home Core Sets)

CMS · Comment closes · Jul 31

CMS-10398 #17 (CHIP State Plan Eligibility)

CMS · Comment closes · Jul 31

DEA · Comment closes · Jul 31

DEA · Comment closes · Jul 31

DEA · Comment closes · Jul 31

6–10 of 57

Browse the document archive